Indeed, in the present study, ACA+ patients with dcSSc had a higher incidence of involvement of internal organs, such as ILD, cardiac and SRC, compared with ACA+ limited, despite the known protective role of ACA for these organ complications. The gene discussed is SRC; the disease is interstitial lung disease.